The TAILORED-AF trial used artificial intelligence (AI)-guided mapping to enhance catheter ablation in persistent atrial fibrillation and demonstrated reductions in recurrent atrial fibrillation, but the net clinical benefit remains unclear.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Comparison of artificial intelligence-adjudicated spatiotemporal dispersion in spontaneous vs. induced atrial fibrillation among patients with persistent AF
Journal of Interventional Cardiac Electrophysiology Open Access 08 September 2025
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Verma, A. et al. N. Engl. J. Med. 372, 1812–1822 (2015).
Spitzer, S. G. et al. Europace 25, 74–82 (2023).
Tzeis, S. et al. Heart Rhythm 21, e31–e149 (2024).
DeLurgio, D. B. et al. Circ. Arrhythm. Electrophysiol. 13, e009288 (2020).
Sang, C. et al. JAMA 333, 381–389 (2025).
Deisenhofer, I. et al. Nat. Med. https://doi.org/10.1038/s41591-025-03517-w (2025).
Seitz, J. et al. Heart Rhythm 21, 540–552 (2024).
Seitz, J. et al. J. Cardiovasc. Electrophysiol. 33, 2250–2260 (2022).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Z.L. is supported by grants from the Department of Veterans Affairs and Boston Scientific, and serves as a consultant for Huxley Medical and Boston Scientific. J.P.P. is supported by R01AG074185 from the National Institutes of Aging; receives grants for clinical research from Abbott, the American Heart Association, Boston Scientific, iRhythm and Philips; and serves as a consultant to Abbott, ABVF/Symkardia, Bayer, Kardium, Medtronic, Milestone Pharmaceuticals, Novartis, Sanofi, Philips and Up-to-Date.
Rights and permissions
About this article
Cite this article
Loring, Z., Piccini, J.P. TAILORing AI-guided treatment for atrial fibrillation. Nat Med 31, 1073–1074 (2025). https://doi.org/10.1038/s41591-025-03611-z
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41591-025-03611-z
This article is cited by
-
Comparison of artificial intelligence-adjudicated spatiotemporal dispersion in spontaneous vs. induced atrial fibrillation among patients with persistent AF
Journal of Interventional Cardiac Electrophysiology (2025)
